Mortgage industry executive

Florida’s Condo Lending Crisis May Finally Ease — And Industry Leaders Expect Big December News

Florida’s real estate market may be on the verge of a major turning point. After nearly two decades under uniquely restrictive lending rules, a long‑running push to bring Florida’s condo loan standards back in line with the rest of the nation may finally be gaining traction.

According to Mortgage Professional America, a reform effort targeting a 2008 Fannie Mae policy—one that applies only to Florida—has accelerated. Since that policy’s introduction, buyers in the Sunshine State have been limited to 75% loan‑to‑value (LTV) on limited‑review condo loans, while all other states allow 90% LTV.

A Two‑Decade Policy Under Fire

Max Slyusarchuk, founder and CEO of A&D Mortgage, has become one of the most outspoken advocates for change. He argues that the 25% down payment requirement has drained both affordability and condo association reserves, creating long‑term financial strain.

“I told Fannie Mae that we think the Florida condo collapse is their fault. You need 25% down. You don’t have any money left for maintenance… and because of less maintenance, the collapse happens.”

Now, after years of pressure from mortgage leaders and the Florida Association of Mortgage Professionals, Slyusarchuk says the movement is close to victory—with hopes of official updates from Fannie Mae in December.

Why These Changes Matter

If the restrictions are removed, the impact could be transformative. Returning to the standard 10% down payment could boost liquidity, improve maintenance funding, and stabilize condo values statewide.

“Number one, it’s going to increase the amount of money available for maintenance. Number two, it’s going to stabilize the market… It’s a big deal.”

Affordability at the Heart of the Issue

In many Florida cities, condos remain one of the last accessible paths to homeownership. But the 25% down payment requirement often pushes first‑time buyers out of the market entirely.

“Sometimes you can buy a condo for $200,000 where a house is $500,000,” Slyusarchuk said. “To ask someone for a $50,000 down payment is unreal.”

Rising insurance premiums and limited inventory magnify the challenge—pressures every Florida real estate agent and mortgage professional knows too well.

Growing Optimism Across the Industry

Other leaders share this optimism. Danielle Blake of the Miami Association of Realtors previously questioned why Florida alone is held to stricter standards, noting that confidence has grown due to increased representation in federal housing discussions.

Now, all eyes are on December—when Florida may finally see its condo lending rules align with national norms.

If you’re building or advancing your career in real estate, mortgage, insurance, or other licensed professions, staying informed on regulatory shifts is crucial. Cameron Academy offers modern, flexible, high‑impact licensing courses across all 50 states—designed for today’s ambitious professionals.

Article source: Mortgage Professional America

More Articles

Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!

The Remote Work Revolution: Redefining Real Estate

Imagine a morning where the commute is just a few steps from your bedroom to your home office. This is the reality for many in today's post-pandemic world, where remote work has become a staple of the modern workforce.

By |December 2, 2024|Categories: Article, Real Estate, Remote Work|Tags: , |0 Comments

CRISPR: The Future of Gene Editing and Its Clinical Implications

CRISPR technology has become the frontrunner in genome editing, surpassing earlier methods like zinc finger nucleases and transcription activator-like effector nucleases. The recent FDA approval of the CRISPR-Cas9 drug, exa-cel, marks a significant milestone particularly for treating sickle cell disease and transfusion-dependent beta thalassemia.

By |December 1, 2024|Categories: Article, Biotechnology, Medicine|Tags: , |0 Comments

AI Revolution in Oncology: Transformative Potential or Overhyped?

In recent years, artificial intelligence has emerged as a revolutionary tool in the field of oncology. AI's integration into healthcare transcends buzzwords, transforming cancer diagnosis, treatment personalization, and drug discovery.

AI in Radiology: A Double-Edged Sword

The rapid advancements in artificial intelligence (AI) are transforming the landscape of radiology, promising to enhance diagnostic accuracy and support personalized medicine. However, as this technology becomes more integral to medical imaging, it brings with it a host of ethical and societal considerations that cannot be ignored.

Humanity at the Crossroads: Ethical Implications of AI in Medicine

AI's promise in healthcare is undeniable, with its ability to uncover hidden disease patterns and predict illnesses. However, the reliance on historical data can exacerbate existing biases, particularly affecting marginalized communities such as the LGBTQIA+ and certain ethnic and racial groups.

The Future of Telemedicine: Challenges and Opportunities Beyond the Pandemic

Telemedicine stands out as a transformative force, offering a lifeline to patients and providers alike. As we move beyond the pandemic, the challenge is to integrate this technology without escalating costs or overshadowing the indispensable role of in-person consultations.

By |November 30, 2024|Categories: Article, Healthcare, Technology|Tags: , |0 Comments